Most Recent

image: Submit Your Innovations Today!

Submit Your Innovations Today!

By | August 29, 2012

You have until the end of this week (Sept. 21 @ 11:59 PM, EDT) to submit your product to The Scientist's 2012 Top 10 Innovations. Be sure to enter your innovative products!

0 Comments

image: Clinical Trial Misfortune

Clinical Trial Misfortune

By | August 28, 2012

A human trial of a hepatitis C treatment is shut down after one of the participants died.

1 Comment

image: Cancer-Causing Gut Bacteria

Cancer-Causing Gut Bacteria

By | August 17, 2012

Mice with inflammatory bowel disease harbor gut bacteria that damage host DNA, predisposing mice to cancer.

1 Comment

image: Immunologist Falsified Data

Immunologist Falsified Data

By | August 6, 2012

A researcher from the John Wayne Cancer Institute has settled his scientific misconduct case with the Office of Research Integrity.

9 Comments

image: Lymphatic Lines

Lymphatic Lines

By | August 1, 2012

Lymphatic vessels grow towards two chemokines, revealing signals that could be important in cancer metastasis.

0 Comments

image: Space-bound Fish

Space-bound Fish

By | July 31, 2012

Japanese astronauts deliver an aquarium to the International Space Station to study the effects of microgravity on marine life.

0 Comments

image: Skin Microbes Alter Immunity

Skin Microbes Alter Immunity

By | July 30, 2012

Like commensal gut organisms, skin microbiota appear to help the mammalian immune system mature and stay regulated.

0 Comments

image: Ubiquitin Chains in Action

Ubiquitin Chains in Action

By | July 1, 2012

Present in every tissue of the body, ubiquitin appears to be involved in a dizzying array of functions, from cell cycle and division to organelle and ribosome biogenesis, as well as the response to viral infection. The protein plays at least two role

0 Comments

image: The Fungus Among Us

The Fungus Among Us

By | June 11, 2012

Researchers find a slew of new fungal species inhabiting the human gut, and suggest a link to an inflammatory bowel disease.

1 Comment

image: Parkinson's Vax Enters Clinical Trials

Parkinson's Vax Enters Clinical Trials

By | June 7, 2012

Researchers in Vienna are starting a Phase I trial on the first ever vaccine with a potential to treat the neurodegenerative disease.

0 Comments

Advertisement
Lonza
Lonza

Popular Now

  1. Antibody Alternatives
    Features Antibody Alternatives

    Nucleic acid aptamers and protein scaffolds could change the way researchers study biological processes and treat disease.

  2. The Mycobiome
    Features The Mycobiome

    The largely overlooked resident fungal community plays a critical role in human health and disease.

  3. Circadian Clock and Aging
    Daily News Circadian Clock and Aging

    Whether a critical circadian clock gene is deleted before or after birth impacts the observed aging-related effects in mice.

  4. Biologist Resigns Amid Sexual Misconduct Probe
Advertisement
INTEGRA
INTEGRA
Advertisement
Life Technologies